Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01564316
  4. Details
NCT01564316 Clinical Trial

Proteomics Study by Serum and Platelet With Neurodegeneration Disease Patients

Biomarker With Neurodegeneration Patients Clinical Trial

Official title:
Proteomics Study by Serum and Platelet With Neurodegeneration Disease Patients

Clinical Trial Details — Status: Terminated

Administrative data
NCT number NCT01564316
Other study ID # H-0505-148-016
Secondary ID
Status Terminated
Phase Phase 0
First received March 11, 2012
Last updated April 14, 2016
Start date May 2005
Est. completion date January 2014

Study information
Verified date March 2016
Source Seoul National University Hospital
Contact n/a
Is FDA regulated No
Health authority Korea: Institutional Review Board
Study type Observational

Clinical Trial Summary

Using to method of Proteomics, for aims to conquer intractable disease, try to access variety experiment. Biomarker is necessary to develop new diagnosis method and target of treatment.

Description:

Following Seoul National University Hospital Institutional Review Board approval, obtain serum and platelet with neurodegeneration patients and control group visited the part of neurology, there'll be analysis to differentiate each other diseases use to method Proteomics. Biomarker will be screening via 1D/2D analysis, Mass analysis, database searching- the MASCOT search tool, SWISS-PROT and etc.

Recruitment information / eligibility
Status Terminated
Enrollment 22
Est. completion date January 2014
Est. primary completion date January 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- neurodegeneration patients and control group include dementia patients visited the part of neurology.

- over the age of 18

- when participants can understand subject of this study

- Total point of Mini Mental state exam(MMSE)should be Under 26 include MCI (mild cognitive impairment) and over GDS score 3points.

exclusion criteria:

- under eighteen years of age

- when participants cannot understand subject of this study

- cannot accept this study

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

Locations
Country Name City State
Korea, Republic of Department of Neurology, Seoul National University Hospital Seoul

Sponsors (1)
Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of,